arrow
E

Elisa Redl

european translational oncology prevention and screening institute
H指数:8
被引数:363

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Short-term hormonal modulation with mifepristone does not induce oncogenic changes in the endometrium of BRCA1/2 pathogenic variant carriers

使用米非司酮进行短期激素调节不会在BRCA1/2致病性变异携带者的子宫内膜中诱导致癌性改变。

2026-02-110
OA
The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancer
2026-01-290
OAAI
Epigenetic signatures in surrogate tissues are able to assess cancer risk and indicate the efficacy of preventive measures

表观遗传学标志物在替代组织中的检测能够评估癌症风险并指示预防措施的有效性。

2025-04-020
OA
Performance of the WID-qEC test to detect uterine cancers in black women with abnormal uterine bleeding: A prospective observational cohort study in Ghana
2024-12-100
PRE
High performance of the DNA methylation-based WID-qEC test for detecting uterine cancers independent of sampling modalities
2024-05-133
OA
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway

STAT3/LKB1通过调控mTORC1/CREB通路调控转移性前列腺癌

2023-08-1214
OAAI
The WID-qEC test: Performance in a hospital-based cohort and feasibility to detect endometrial and cervical cancers

Wid-qec测试: 在基于医院的队列中的表现以及检测子宫内膜癌和宫颈癌的可行性

2022-10-019
OAAI
Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies

鉴定肿瘤组织来源的DNA甲基化生物标志物,用于液体活检中转移性去势抵抗性前列腺癌的检测和治疗反应评估

2022-01-0312
OAAI
Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis

需要DNMT1来协调npm-alk驱动的淋巴瘤发生的表观基因组重编程

2020-12-116
OAAI